H.R. 1758 - 118th Congress (2023-2024) - SIFT Act of 2023

This bill permanently adds five fentanyl analogues and the entire category of fentanyl-related substances to schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act.

Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires on December 31, 2024.

The bill also creates a process to remove from schedule I certain fentanyl-related substances that do not have a high potential for abuse.

Text (1)

Introduced in House

March 23, 2023

Actions (3)

Show Only Major Actions

05/09/2023

Referred to the Subcommittee on Health.

03/23/2023

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

03/23/2023

Introduced in House

Public Record

Record Updated

Mar 18, 2024 9:22:27 PM